FGDIX
Price
$58.03
Change
-$2.14 (-3.56%)
Updated
Jun 3 closing price
Net Assets
4.23B
INIIX
Price
$39.30
Change
-$1.30 (-3.20%)
Updated
Jun 3 closing price
Net Assets
1.58B
Interact to see
Advertisement

FGDIX vs INIIX

Header iconFGDIX vs INIIX Comparison
Open Charts FGDIX vs INIIXBanner chart's image
FGDIX vs INIIX Comparison Chart in %
View a ticker or compare two or three
VS
FGDIX vs. INIIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGDIX is a Hold and INIIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FGDIX has more cash in the bank: 4.23B vs. INIIX (1.58B). FGDIX pays higher dividends than INIIX: FGDIX (4.70) vs INIIX (3.93). FGDIX was incepted earlier than INIIX: FGDIX (19 years) vs INIIX (20 years). INIIX (1.06) is less costly to investors than FGDIX (0.69). FGDIX is a more actively managed with annual turnover of: 60.00 vs. INIIX (30.00). FGDIX has a lower initial minimum investment than INIIX: FGDIX (0) vs INIIX (1000000). INIIX annual gain was more profitable for investors over the last year : 73.43 vs. FGDIX (61.65). INIIX return over 5 years is better than : 160.79 vs. FGDIX (112.82).
FGDIXINIIXFGDIX / INIIX
Total Expense Ratio0.691.0069%
Annual Report Gross Expense Ratio0.691.0665%
Fund Existence19 years20 years-
Gain YTD5.3824.355124%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.23B1.58B268%
Annual Yield % from dividends4.703.93120%
Returns for 1 year61.6573.4384%
Returns for 3 years177.94220.2681%
Returns for 5 years112.82160.7970%
Returns for 10 years208.87323.8365%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLEC8.221.39
+20.35%
Moolec Science SA
INCY97.975.73
+6.21%
Incyte Corp
TOYO16.45-0.28
-1.67%
Toyo Co Ltd
ATRO83.51-2.10
-2.45%
Astronics Corp
ENGN1.67-0.07
-4.02%
enGene Therapeutics Inc